Sellbyville, DE -- (SBWIRE) -- 12/14/2018 -- Global Microsurgery robot Market is set to exceed USD 1.7 billion by 2024; according to a new research report by Global Market Insights.

Technological advancements in microsurgery robot allowing effective treatment of various chronic disorders is forecasted to boost market growth during the foreseeable future. Advances such as miniaturization of robotic arms aid to reduce complications and undesirable effects post-surgery will foster business growth. For instance, in October 2017, surgeons from Maastricht University in Netherlands carried out microsurgery for suturing blood vessels of 0.3 mm for treatment of lymphedema. Such advancements will propel microsurgery robot industry growth during the projected timeframe.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2814

Oncology surgery segment will grow at a momentous rate of 15.7% during the forecast timeframe owing to high pervasiveness of cancer. According to World Health Organization, in 2015, more than 24.6 million people worldwide suffered from cancer. Robotic surgery can be employed for treatment of various cancers such as prostate cancer, colorectal cancer, head and neck cancer. Shorter recovery time and low post-operative complication are few of the advantages offered by robotic-assisted cancer treatment. Such factors will favour segmental growth in recent years.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Stryker
2. Smith & Nephew
3. Zimmer Biomet
4. Medtronic
5. Auris Health, Inc
6. Titan Medical Inc
7. TransEnterix, Inc
8. Mazor Robotics
9. Medrobotics Corporation

Hospitals and clinics segment held largest revenue share of 50.7% in 2017. The segmental growth is attributable to growing burden of chronic diseases on healthcare industry. Multi-speciality hospitals offer advanced therapeutic solutions to patients, thereby improving patient outcomes. Affordability of hospitals to buy technologically advanced robotic systems and increasing adoption of minimally invasive surgical procedures will increase demand for microsurgery robot in forthcoming period.

Ambulatory surgical centers segment will grow with a remarkable rate of 14.5% during the forecast timeframe. High growth rate is credited to cost-effective treatment options provided by ambulatory surgical centers. Reduction in length of stay in ambulatory surgical centers is major factor propelling segmental growth. As there is high adoption rate of surgical robots in ambulatory surgical centers for providing minimal invasive surgery, segmental growth will be tremendous in the future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2814

U.S. microsurgery robot market contributed to the largest revenue of USD 355.1 million in North America in 2017. High per-capita and disposable income will enable patients to opt microsurgical robot for various surgical procedures. According to General Surgery News, in 2015, about 140 thousand robotic general surgeries were performed in U.S. Microsurgical robot is widely used in U.S. due to growing demand for minimally invasive surgical procedures. This will foster regional growth in foreseeable years.

Microsurgery Robot Market, by Application
o Ophthalmology surgery
o Cardiovascular surgery
o Neurovascular surgery
o Gastrointestinal surgery
o Obstetrics and Gynecology surgery
o Urology surgery
o Oncology surgery
o ENT surgery
o Reconstructive surgery
o Micro anastomosis
o Ureterorenoscopy